← Back to Analyst Consensus 
MD Hold
Pediatrix Medical Group, Inc.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 19, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Aug 6, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Jul 14, 2026 | Truist Securities | maintain | Hold → Hold | — | 55% |
| May 12, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Apr 13, 2026 | Truist Securities | maintain | Hold → Hold | — | 55% |
| Feb 24, 2026 | UBS | maintain | Neutral → Neutral | $22 | 54% |
| Feb 20, 2026 | Truist Securities | maintain | Hold → Hold | $21 | 55% |
| Nov 10, 2025 | Truist Securities | maintain | Hold → Hold | $24 | 55% |
| Nov 5, 2025 | UBS | maintain | Neutral → Neutral | $23 | 54% |
| Sep 5, 2025 | Leerink Partners | maintain | Market Perform → Market Perform | $17 | 50% |
| Aug 14, 2025 | UBS | maintain | Neutral → Neutral | $16.5 | 54% |
| May 12, 2025 | UBS | maintain | Neutral → Neutral | $16 | 54% |
| May 8, 2025 | Macquarie | maintain | Outperform → Outperform | $20 | 56% |
| Apr 11, 2025 | Truist Securities | maintain | Hold → Hold | $16 | 55% |
| Feb 21, 2025 | UBS | maintain | Neutral → Neutral | $18.5 | 54% |
| Feb 21, 2025 | Truist Securities | maintain | Hold → Hold | $18 | 55% |
| Jan 6, 2025 | Truist Securities | maintain | Hold → Hold | $15 | 55% |
| Dec 16, 2024 | Macquarie | initiate | — → Outperform | $18 | 56% |
| Nov 19, 2024 | Mizuho | maintain | Neutral → Neutral | $15 | 52% |
| Nov 5, 2024 | UBS | maintain | Neutral → Neutral | $16.5 | 54% |
| Nov 5, 2024 | Jefferies | maintain | Buy → Buy | $18 | 52% |
| Nov 4, 2024 | Deutsche Bank | maintain | Hold → Hold | $15 | 57% |
| Nov 4, 2024 | Truist Securities | maintain | Hold → Hold | $16 | 55% |
| Nov 4, 2024 | Mizuho | maintain | Neutral → Neutral | $15 | 52% |
| Oct 7, 2024 | Truist Securities | maintain | Hold → Hold | $13 | 55% |
| Sep 26, 2024 | Jefferies | upgrade | Hold → Buy | $14 | 52% |
| Aug 15, 2024 | Truist Securities | maintain | Hold → Hold | $10 | 55% |
| Aug 9, 2024 | UBS | maintain | Neutral → Neutral | $10.5 | 54% |
| Jul 15, 2024 | Truist Securities | maintain | Hold → Hold | $8 | 55% |
| Jun 7, 2024 | Deutsche Bank | upgrade | Sell → Hold | $8 | 57% |
| May 15, 2024 | Truist Securities | maintain | Hold → Hold | $10 | 55% |
| Mar 6, 2024 | Jefferies | maintain | Hold → Hold | $9 | 52% |
| Feb 21, 2024 | Mizuho | maintain | Neutral → Neutral | $9 | 52% |
| Feb 21, 2024 | Truist Securities | maintain | Hold → Hold | $10 | 55% |
| Nov 30, 2023 | UBS | initiate | — → Neutral | $9.5 | 54% |
| Oct 11, 2023 | Truist Securities | maintain | Hold → Hold | $15 | 55% |
| May 9, 2023 | Truist Securities | maintain | — → Hold | $15 | 55% |
| Feb 22, 2023 | Credit Suisse | maintain | — → Outperform | $23 | — |
| Dec 5, 2022 | Credit Suisse | maintain | — → Outperform | $27 | — |
| Nov 16, 2022 | Mizuho | maintain | — → Neutral | $17 | 52% |
| Nov 4, 2022 | SVB Leerink | maintain | — → Market Perform | $16 | — |
| Aug 11, 2022 | Credit Suisse | maintain | — → Outperform | $28 | — |
| Aug 10, 2022 | BMO Capital | maintain | — → Market Perform | $23 | 53% |
| May 12, 2022 | SVB Leerink | maintain | — → Market Perform | $20 | — |
| May 3, 2022 | Credit Suisse | maintain | — → Outperform | $30 | — |
| May 2, 2022 | Mizuho | maintain | — → Neutral | $23 | 52% |
| Apr 27, 2022 | SVB Leerink | maintain | — → Market Perform | $24 | — |
| Feb 23, 2022 | Credit Suisse | maintain | — → Outperform | $31 | — |
| Dec 22, 2021 | Credit Suisse | maintain | — → Outperform | $32 | — |
| Nov 4, 2021 | SVB Leerink | maintain | — → Market Perform | $27 | — |
Price Target Trend
Mar 27, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
0y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days